Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The high-resolution crystal structure of periplasmicHaemophilus influenzaeNAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism
Silvia Garavaglia, Santina Bruzzone, C. Cassani, et al.
Biochemical Journal (2011) Vol. 441, Iss. 1, pp. 131-141
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

NAD + in aging, metabolism, and neurodegeneration
Eric Verdin
Science (2015) Vol. 350, Iss. 6265, pp. 1208-1213
Closed Access | Times Cited: 1032
Cellular function and molecular structure of ecto-nucleotidases
Herbert Zimmermann, M. Zebisch, Norbert Sträter
Purinergic Signalling (2012) Vol. 8, Iss. 3, pp. 437-502
Open Access | Times Cited: 924
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Wusheng Xiao, Rui‐Sheng Wang, Diane E. Handy, et al.
Antioxidants and Redox Signaling (2017) Vol. 28, Iss. 3, pp. 251-272
Open Access | Times Cited: 740
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Michael S. Bonkowski, David Sinclair
Nature Reviews Molecular Cell Biology (2016) Vol. 17, Iss. 11, pp. 679-690
Open Access | Times Cited: 708
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten, Susanne Schuster, Melanie Penke, et al.
Nature Reviews Endocrinology (2015) Vol. 11, Iss. 9, pp. 535-546
Closed Access | Times Cited: 575
The adenosine pathway in immuno-oncology
Bertrand Allard, David Allard, Laurence Buisseret, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 611-629
Closed Access | Times Cited: 397
NAD+ metabolism, stemness, the immune response, and cancer
Lola E. Navas, Amancio Carnero
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 327
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
M. Di Stefano, Isabel Nascimento-Ferreira, Giuseppe Orsomando, et al.
Cell Death and Differentiation (2014) Vol. 22, Iss. 5, pp. 731-742
Open Access | Times Cited: 239
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
Alberto L. Horenstein, Antonella Chillemi, Gianluca Zaccarello, et al.
OncoImmunology (2013) Vol. 2, Iss. 9, pp. e26246-e26246
Open Access | Times Cited: 238
The human NAD metabolome: Functions, metabolism and compartmentalization
Andrey Nikiforov, Veronika Kulikova, Mathias Ziegler
Critical Reviews in Biochemistry and Molecular Biology (2015) Vol. 50, Iss. 4, pp. 284-297
Open Access | Times Cited: 203
Modulating NAD+ metabolism, from bench to bedside
Elena Katsyuba, Johan Auwerx
The EMBO Journal (2017) Vol. 36, Iss. 18, pp. 2670-2683
Open Access | Times Cited: 195
Evolving concepts in NAD+ metabolism
Claudia C.S. Chini, Julianna D. Zeidler, Sonu Kashyap, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1076-1087
Open Access | Times Cited: 169
A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death
Zhi Ying Zhao, Xu Jie Xie, Wan Hua Li, et al.
iScience (2019) Vol. 15, pp. 452-466
Open Access | Times Cited: 164
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation
Valentina Audrito, Vincenzo Gianluca Messana, Silvia Deaglio
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 155
NAD + homeostasis in human health and disease
Rubén Zapata‐Pérez, Ronald J. A. Wanders, Clara D.M. van Karnebeek, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 7
Open Access | Times Cited: 142
TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD + METABOLITES
Samuel A.J. Trammell, Charles Brenner
Computational and Structural Biotechnology Journal (2013) Vol. 4, Iss. 5, pp. e201301012-e201301012
Open Access | Times Cited: 179
Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
Karen Knapp, M. Zebisch, Jan Pippel, et al.
Structure (2012) Vol. 20, Iss. 12, pp. 2161-2173
Open Access | Times Cited: 176
CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-treated Tumor Cells
Alessia Grozio, Giovanna Sociali, Laura Sturla, et al.
Journal of Biological Chemistry (2013) Vol. 288, Iss. 36, pp. 25938-25949
Open Access | Times Cited: 149
NAD+ salvage pathway in cancer metabolism and therapy
Barry E. Kennedy, Tanveer Sharif, Emma Martell, et al.
Pharmacological Research (2016) Vol. 114, pp. 274-283
Closed Access | Times Cited: 125
Cd73: An Emerging Checkpoint for Cancer Immunotherapy
Siqi Chen, Derek A. Wainwright, Jennifer D. Wu, et al.
Immunotherapy (2019) Vol. 11, Iss. 11, pp. 983-997
Open Access | Times Cited: 106
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin
Federico Carbone, Luca Liberale, Aldo Bonaventura, et al.
Comprehensive physiology (2017), pp. 603-621
Closed Access | Times Cited: 102
Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity
Anna Wilk, Faisal Hayat, Richard P. Cunningham, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 74
Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside
Łukasz Mateuszuk, Roberto Campagna, Barbara Kutryb-Zając, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114019-114019
Open Access | Times Cited: 71
Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men
Masaki Igarashi, Yoshiko Nakagawa-Nagahama, Masaomi Miura, et al.
npj Aging (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 66
Reduced nicotinamide mononucleotide is a new and potent NAD+precursor in mammalian cells and mice
Rubén Zapata‐Pérez, Alessandra Tammaro, Bauke V. Schomakers, et al.
The FASEB Journal (2021) Vol. 35, Iss. 4
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top